Dec 17, 2020

COVID vaccine made from GMO tobacco? It’s now in human trials

Posted by in categories: biotech/medical, genetics

“BAT said KBP had cloned a portion of the genetic sequence of coronavirus and developed a potential antigen, which is then inserted into tobacco plants for reproduction.”


While large pharmaceutical companies are already producing vaccines, [the company British American Tobacco] believes its own can be produced in six weeks, compared with the several months it takes using conventional methods.

This, the company claims, is because of proprietary technology that allows elements of the vaccine to gather quickly on tobacco plants.

BAT also says its vaccine is stable at room temperature, unlike the Pfizer/BioNTech jab being administered in the UK, which must be stored and transported at about-70C.

Leave a reply